Successful Management of Osimertinib-Induced Heart Failure

Cancer therapeutics-related cardiac dysfunction is currently of great concern as one of the pivotal therapeutic targets of onco-cardiology. Only a few studies have reported the occurrence of heart failure following the administration of osimertinib, a third-generation epidermal growth factor recepto...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuo, Atsuko, Imamura, Teruhiko, Onoda, Hiroshi, Kinugawa, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876205/
https://www.ncbi.nlm.nih.gov/pubmed/35208635
http://dx.doi.org/10.3390/medicina58020312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876205/
https://www.ncbi.nlm.nih.gov/pubmed/35208635
http://dx.doi.org/10.3390/medicina58020312

Ejemplares similares